We are live on ! Find out more
FCMV

Foresite Capital Management V Portfolio holdings

AUM $271M
1-Year Est. Return 309.87%
This Fund
S&P 500
This Quarter Est. Return
+24.3%
1 Year Est. Return
+309.87%
3 Year Est. Return
+356.88%
5 Year Est. Return
+250.56%
10 Year Est. Return
–
AUM
$135M
AUM Growth
+$6.52M
Cap. Flow
+$394K
Cap. Flow %
0.29%
Top 10 Hldgs %
99.8%
Holding
11
New
–
Increased
2
Reduced
2
Closed
–

Top Buys

Rank Stock Value
1
KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
+$6.7M
2
QSI icon
Quantum-Si Incorporated
QSI
+$49

Top Sells

Rank Stock Value
1
CMPX icon
Compass Therapeutics
CMPX
+$3.61M
2
HIMS icon
Hims & Hers Health
HIMS
+$2.7M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HIMS icon
1
Hims & Hers Health
HIMS
$6.26B
$37M 27.38%
3,733,381
-308,002
-8% -$2.7M
THRX
2
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$31.8M 23.54%
3,585,346
– –
PRDS
3
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$13.3M 9.79%
10,037,935
– –
KNTE
4
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$12.3M 9.13%
1,975,001
+1,100,000
+126% +$6.7M
CMPX icon
5
Compass Therapeutics
CMPX
$349M
$11.4M 8.41%
3,480,723
-919,277
-21% -$3.61M
ACRS icon
6
Aclaris Therapeutics
ACRS
$743M
$10.2M 7.52%
1,258,243
– –
SLGC
7
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$8.97M 6.63%
3,516,472
– –
IRON icon
8
Disc Medicine
IRON
$3.03B
$5.16M 3.81%
243,513
– –
ACET icon
9
Adicet Bio
ACET
$84.7M
$3.22M 2.38%
34,915
– –
QSI icon
10
Quantum-Si Incorporated
QSI
$157M
$1.63M 1.2%
924,404
+25
+0% +$49
PHVS icon
11
Pharvaris
PHVS
$2.37B
$275K 0.2%
34,142
– –

Similar funds

MAM
Mullooly Asset Management Wall Township, New Jersey $271M AUM 16.93% 1-Year Est. Return
MLM
Mount Lucas Management Newtown, Pennsylvania $271M AUM 25.49% 1-Year Est. Return
MCM
Moerus Capital Management New York $271M AUM 58.78% 1-Year Est. Return
RP
Ravenswood Partners Mclean, Virginia $271M AUM
PCM
Punch Card Management Winter Park, Florida $271M AUM 11.49% 1-Year Est. Return
S
Siemens Munich, Germany $272M AUM 183.71% 1-Year Est. Return
VW
Veridan Wealth West Linn, Oregon $270M AUM
TP
TritonPoint Partners Chevy Chase, Maryland $272M AUM

Foresite Capital Management V's Q1 2023 Portfolio in Review

As of Q1 2023, Foresite Capital Management V held 11 positions worth $135M, up 5.1% from $129M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2023: portfolio turnover was 0%. Foresite Capital Management V opened no new positions and made no exits, leaving the 11-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Foresite Capital Management V added most to Kinnate Biopharma Inc. Common Stock in Q1 2023, an estimated $6.7M increase.
  • Foresite Capital Management V's biggest Q1 2023 reduction was Compass Therapeutics, cutting an estimated $3.61M.
  • Foresite Capital Management V's ten largest holdings make up 100% of its $135M portfolio in Q1 2023.
  • Foresite Capital Management V opened 0 new positions and closed 0 in Q1 2023.
  • Foresite Capital Management V's portfolio value rose 5.1% quarter-over-quarter to $135M.

Based on Foresite Capital Management V's 13F filing for Q1 2023, filed 12 May 2023.